Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Videos

Cell substrates: lessons learned and challenges remaining.

J C Petricciani

Developments in Biological Standardization

|January 1, 2000

Summary

This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

The acceptability of continuous cell lines: A personal & historical perspective.

Cytotechnology·2012

Same author

An overview of viral and viral-like agents in cell culture systems.

Cytotechnology·2008

Same author

Recent trends in cell substrate considerations for continuous cell lines.

Current opinion in biotechnology·2001

Same author

Recombinant DNA vaccines and therapeutics.

Lancet (London, England)·2000

Same author

International acceptance of blood and blood products.

Developments in biologicals·2000

Same author

Karyology and tumorigenicity testing requirements: past, present and future.

Developments in biological standardization·1998

Same journal

International challenges and public policy issues.

Developments in biological standardization·2000

Same journal

Regulation of biologicals in China.

Developments in biological standardization·2000

Same journal

ICH activities on biotech topics.

Developments in biological standardization·2000

Same journal

Regulation of biologicals in the European Union.

Developments in biological standardization·2000

Same journal

Standardisation and licensing of combination vaccines based on DTP.

Developments in biological standardization·2000

Same journal

Control of foot-and-mouth disease by vaccination.

Developments in biological standardization·2000

See all related articles

Cell substrates for biological products evolved with technical advances, presenting challenges and requiring cooperation. Ongoing collaboration is crucial for resolving remaining issues in live viral vaccine production.

Area of Science:

Biotechnology
Cell Biology
Vaccinology

Background:

Cell culture techniques advanced biological product manufacturing starting in the 1950s.
Human diploid cells (HDCs) emerged in the 1960s as an alternative to primary cells for live viral vaccines.
Continuous cell lines (CCLs) were developed in the 1970s for non-replicating products like interferon.

Observation:

Recombinant DNA and monoclonal antibody technologies in the 1980s necessitated the use of CCLs.
While many CCL issues for biological products are resolved, challenges persist for live viral vaccine substrates.
Historical technical challenges often took over a decade to resolve, highlighting the need for sustained effort.

Findings:

The evolution of cell substrates reflects a history of innovation and adaptation in biological manufacturing.

Related Experiment Videos

CCLs are widely used but present specific challenges for live viral vaccine production.

Cooperation between regulatory bodies, industry, and the scientific community is essential for addressing technical hurdles.

Implications:

Continued collaboration, potentially led by organizations like the World Health Organization, is vital for advancing biological product manufacturing.
Resolving outstanding issues with CCLs for live viral vaccines will enhance vaccine safety and availability.
A consensus-driven approach to new technologies ensures the best interests of public health and the biomedical community are met.